News
LUND, Sweden, July 8, 2025 /PRNewswire/ — Hansa Biopharma AB, “Hansa” (NASDAQ Stockholm: HNSA) today announced that Dr. Richard Philipson has been appointed Chief Medical Officer (CMO) effective 14 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results